Wealthedge Investment Advisors, LLC Bristol Myers Squibb CO Transaction History
Wealthedge Investment Advisors, LLC
- $240 Billion
- Q2 2025
A detailed history of Wealthedge Investment Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wealthedge Investment Advisors, LLC holds 96,686 shares of BMY stock, worth $4.2 Million. This represents 1.86% of its overall portfolio holdings.
Number of Shares
96,686Holding current value
$4.2 Million% of portfolio
1.86%Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,668Shares Held
1.63BCall Options Held
22.4MPut Options Held
25.4M-
Vanguard Group Inc Valley Forge, PA195MShares$8.46 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$6.88 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.69 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.11 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.07 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $92.3B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...